Tirabrutinib,
1351636-18-4,
UNII-LXG44NDL2T,
LXG44NDL2T,
Btk Kinase inhibitor,
Tirabrutinib [INN],
ONO-4059(Free base),
CHEMBL4071161,
SCHEMBL14798454,
BDBM194087,
EX-A2358,
ZINC72318699,
AKOS030526437,
CS-5676,
SB22940,
ONO-4059; Tirabrutinib; GS-4059,
HY-15771,
F10085,
US9199997, 9,
(R)-6-amino-9-(1-(but-2-ynoyl)pyrrolidin-3-yl)-7-(4-phenoxyphenyl)-7H-purin-8(9H)-one,
6-Amino-9-((3R)-1-(2-butynoyl)-3-pyrrolidinyl)-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one,
6-Amino-9-[(3R)-1-(2-butynoyl)pyrrolidine-3-yl]-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purine-8-one,
8H-Purin-8-one,6-amino-7,9-dihydro-9-((3R)-1-(1-oxo-2-butyn-1-yl)-3-pyrrolidinyl)-7-(4-phenoxyphenyl),
ONO-4059,
GS-4059,
6-amino-7,9-dihydro-9-[(3R)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl]-7-(4-phenoxyphenyl)-8H-purin-8-one(Btk Kinase inhibitor;ONO BTK),